Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates (1995-1997);Evolución de la sensibilidad antimicrobiana en aislamientos clínicos de Acinetobacter baumannii (1995-1997)

Revista Espanola de Quimioterapia

Volumn 13, Issue 4, 2000, Pages 394-400

  Lopez Hernandez S ^a   Alarcon T ^a   Lopez Brea M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Acinetobacter baumannii; Betalactam agents; Nonbetalactams; Susceptibility

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CLAVULANIC ACID; COLISTIN; DOXYCYCLINE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; OFLOXACIN; PIPERACILLIN; RIFAMPICIN; SULBACTAM; SULTAMICILLIN; TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ACINETOBACTER; ACINETOBACTER INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0041372990     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Antimicrobial susceptibility to Acinetobacter species
2. In vitro antimicrobial production of betalactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by susceptibility of clinical isolates of Acinetobacter baumannii
3. Emergence of multidrug-resistant isolates of Acinetobacter baumannii
4. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymixin B and sulbactam
5. Acinetobacter calcoaceticus variety anitratus: An increasing nosocomial problem
6. Activities of β-lactams against Acinetobacter genoespecies as determined by agar dilution and E-test MIC methods
7. Antibacterial activity of cefepime in vitro
8. Rifampin: Spectrum of antibacterial activity
9. Efficacy of various regimen containing rifampin against multi-resistant Acinetobacter baumannii (MRAb) in a mouse pneumonia model
10. Azithromycin in the therapy of ulceroglandular tularemia
11. In vitro activity of azithromycin against Acinetobacter strains resistant to routinely tested betalactams, aminoglycosides, quinolones, and imipenem
12. Topical antibaterials
13. Emergence of a multiply-resistant strain of Acinetobacter in a burns unit
14. International collaborative study on standardization of bacterial sensitivities to fosfomycin
15. Criterios del grupo MENSURA para la definición de los puntos criticos de sensibilidad a los antibióticos
16. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical and epidemiological features
17. Emergence of resistant isolates of Acinetobacter calcoaceticus-A. baumannii complex in a Spanish Hospital over a five-year period
18. Actividad in vitro de 11 antimicrobianos frente a aislamientos clinicos de Acinetobacter spp
19. Sensibilidad de Acinetobacter calcoaceticus-bumannii complex y Acinetobacter lwoffii a los antibióticos de uso cotidiano
20. Carbapenem resistance mediated by betalactamases in clinical isolates of Acinetobacter baumannii in Spain
21. In vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolates
22. Sulbactam/ampicillin: In vivo spectrum, potency, and activity in models of acute infection
23. Sulbactam secondary mechanisms of action
24. Comparative in vitro antimicrobial susceptibilities of nosocomial combinations
25. Effect of a beta-lactamase inhibitor, tazobactam, on growth and penicillin-binding proteins of Borrelia burgdorferi
26. Susceptibility of 238 Acinetobacter strains to 10 β-lactams
27. In vitro activity of colistin and rifampin against multidrug-resistant strains of Acinetobacter baumannii